House bill · 119th Congress · Latest step: Introduced
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026
Official title: To require persons who undertake federally funded research and development of a biomedical product or service to enter into reasonable pricing agreements with the Secretary of Health and Human Services, and for other purposes.
Open in Bill Explorer →Where it went
- IntroducedAug 13, 2026
- Committee action—
- Passed House—
- Passed Senate—
- To the President—
- Became law—
Latest action: Aug 13, 2026 — Referred to the House Committee on Energy and Commerce.
Cost and committee reports
Official records Congress.gov attaches to H.R. 10094.
- Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Ms. HOYLE of Oregon, as printed in the Congressional Record (Vol. 172, No. 132, August 13, 2026, Pages H5235-H5236):This bill is enacted pursuant to the power granted to Congress under Article I of the United States Constitution and its subsequent amendments, and further clarified and interpreted by the Supreme Court of the United States.Source: Congress.gov, Congressional Record August 13, 2026 ↗
Evidence
- Field in the Congress.gov record
- constitutionalAuthorityStatementText
- Statement length
- 224 characters
- Congress.gov bill record
- H.R. 10094, 119th Congress
- Congress.gov API record
- https://api.congress.gov/v3/bill/119/hr/10094
- Record last updated by Congress.gov
- October 10, 2026
- PORKER copy retrieved
- October 10, 2026
- Stored copy, SHA-256 of the file
904d8f627a37f096efa2dbfd136449652abf650ce9fb1978e357d4c560d55af6
PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.
Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of October 10, 2026). Not every bill gets one.
From the Congress.gov bill record for H.R. 10094, last updated October 10, 2026. PORKER’s copy was retrieved October 10, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.
Vote results
No recorded roll-call votes on this bill in PORKER’s records (voice votes and unanimous consent are not roll calls; roll-call records start in 2011).
Cosponsors
15 cosponsors — 15 Democrats
0 of 15 cosponsors (0%) are from the other party.
Greg Casar (D-TX), Steve Cohen (D-TN), Rosa DeLauro (D-CT), Lloyd Doggett (D-TX), Jesús García (D-IL), Pramila Jayapal (D-WA), Ro Khanna (D-CA), Seth Magaziner (D-RI), Eleanor Norton (D-DC), Chellie Pingree (D-ME), Janice Schakowsky (D-IL), Melanie Stansbury (D-NM), Mark Takano (D-CA), Rashida Tlaib (D-MI), Jill Tokuda (D-HI).
More from the sponsor
Other 119th Congress bills sponsored by Rep. Val Hoyle.
- H.R. 164 (119th) POWER Act of 2025
- H.R. 8592 (119th) No WAR Act
- H.R. 1700 (119th) Social Security Expansion Act
- H.R. 10444 (119th) Stop Corporate Takeovers of Physicians Act of 2026
- H.R. 2847 (119th) Vote at Home Act of 2025
- H.R. 4453 (119th) To amend title 5, United States Code, to include Parkinson's disease in the list of illnesses and diseases deemed to be proximately caused…
Sponsor’s state and district
Data as of Oct 19, 2026 · bill record checked by PORKER from Congress.gov · votes from Senate.gov and the House Clerk. PORKER is non-partisan.